How a cheap antidepressant emerged as a promising Covid-19 treatment
Vox reports: Since Covid-19 patients started showing up at clinics and hospitals a year and a half ago, doctors and researchers have been hard at work trying to figure out how to treat them. Most drugs and treatments haven’t panned out, producing either no results or small ones in large-scale clinical trials. Many of the few that work are expensive and difficult to administer. Hydroxychloroquine, enthusiastically endorsed by President Trump last year, has been shown to have no measurable benefits….